Vectus Biosystems: Could this drug eventually prevent thousands of deaths?
Listen to ASX-listed Vectus Biosystems CEO Karen Duggan talk to Matt Birney on the Bulls N’ Bears Report about Vectus’ rapidly developing treatment for a condition that is a factor in up to 40 per cent of all deaths.

Elk Range Mining IPO: This US gold project is anything BUT Greenfields!
03:05

Heavy Minerals Ltd: Who would have thought – multi millions from garnet
03:07

Kalamazoo Resources: Northern Star could’ve bought this project for $30m but didn’t – big mistake!
03:10